RxDoctor Payments Data

Melissa Winter, DPM

Foot & Ankle Surgery · Fort Myers, FLNPI 1770030256

Payments from drug & device makers

$7,252in general payments, 2019–2025

Across 169 payments — averaging $42.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$1K
  • Stryker$1K
  • Organogenesis Inc.$752
  • Amgen$719
  • Treace Medical Concepts, Inc.$495
  • Smith+Nephew$464
  • plus $2K from 22 others

What the payments were for

  • Travel & lodging$4987%
  • Food & beverage$5,55477%
  • Education$1,20017%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex8$1,495
Stryker16$1,396
Organogenesis Inc.30$752
Amgen35$719
Treace Medical Concepts, Inc.11$495
Smith+Nephew11$464
Boston Scientific3$303
Solventum Corporation3$222
Paratek Pharmaceuticals, Inc.6$196
Averitas Pharma Inc.7$179
Kerecis Limited5$144
Coastal Medical Technologies LLC1$141
Medtronic3$125
DJO, LLC3$109
AbbVie(2 entities)5$89
GRT US Holding, Inc.6$72
RSW Medical Company, Inc.1$57
Fidia Pharma USA Inc.3$52
Reprise Biomedical, Inc.2$49
Orthofix Medical, Inc.2$33
Cardiovascular Systems Inc.1$32
Heron Therapeutics, Inc.1$21
Alfasigma USA, Inc.1$21
Johnson & Johnson1$19
Cashflow Solutions, LLC1$18
KCI USA, Inc.1$17
Melinta Therapeutics, LLC1$16
Surgenex LLC1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,252 in reported general payments places this provider in the 70th percentile of 850 foot & ankle surgery providers in Florida.

See all foot & ankle surgery providers in Florida

Medicare billing

Part B allowed, 2024
$772,358
Medicare patients
715
Services billed
5,339

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort34$1,631
Doxycycline Hyclate79$748
Methylprednisolone83$626
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav20$205
Ciprofloxacin Hcl28$203
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen22$136

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Fort Myers

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →